Drug Topics

JULY 21, 2025

Panelists discuss how pharmacists should implement follow-up practices for patients who need additional pneumococcal vaccine doses, including scheduling appointments while patients are present, using text or phone reminders, queuing future vaccine prescriptions in computer systems to align with due dates, utilizing state immunization registries for tracking and alerts when available, and providing patients with vaccination records in their preferred format while ensuring compliance with state in

Scheduling Appointments

Pharmacy Times

JULY 21, 2025

Omolola (Lola) Adeoye-Olatunde, PharmD, MS, discusses findings from a multi-year analysis of American Association of Colleges of Pharmacy (AACP) institutional data on faculty and graduate student representation in pharmacy education, highlighting persistent disparities and offering actionable strategies to improve equity and inclusion in the academic pipeline.

Drug Topics

JULY 21, 2025

Panelists discuss how pharmacists can systematically identify eligible patients through team-based approaches involving technicians and student pharmacists who can query databases by age (50+) and high-risk conditions or medications, while addressing common barriers identified in research including insurance coverage, patient willingness, eligibility determination challenges, documentation time, and patient demand—emphasizing that effective solutions require clear communication, strong provider

Insurance Coverage

Pharmacy Times

JULY 21, 2025

News All News FDA Updates Press Releases Media All Videos Digital Detail Independent Corner Insights Interviews MEDcast Medical World News Microsites Peer Exchange Perfect Consult Podcasts Practice Pearls Sponsored Webcast Student Voices Webinars/Webcasts Conferences Conference Coverage Conference Listing Publications Pharmacy Times Pharmacy Practice in Focus: Oncology Pharmacy Practice in Focus: Health Systems Pharmacy Careers All Publications About the Publications Author Submission Submit to

Vaccines

Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.

The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven

Patient Care

Drug Topics

JULY 21, 2025

A new study reveals the waning effectiveness of 2023-2024 COVID-19 vaccines, highlighting the need for ongoing vaccinations and pharmacist involvement.

Vaccines

Pharma Marketing Network

JULY 21, 2025

Pharmaceutical marketing has evolved far beyond traditional advertising. In a digital-first and HCP-centric world, high impact sponsorships are emerging as a cornerstone strategy for brands aiming to cut through the noise and establish authentic, memorable engagement. But how do these sponsorships deliver superior value compared to other channels? Imagine a specialist at a major medical conference pausing at your branded pavilion—not just to grab a tote bag, but to engage in real-time learning,

Compounding

PharmaVoice

JULY 21, 2025

Skip to main content CONTINUE TO SITE ➞ Dont miss the most important voices in pharma Let PharmaVoices free newsletter keep you informed on what industry leaders are saying, straight from your inbox. By signing up to receive our newsletter, you agree to our Terms of Use and Privacy Policy. You can unsubscribe at anytime. Voices Q&A Profiles Biotech Spotlight First 90 Days Opinions Topics Biotech Commercialization Leadership Manufacturing Patient Pharma Policy & Regulation Research & Deve

FDA

Drug Topics

JULY 21, 2025

Michael Murphy, PharmD, MBA, discusses how the lack of a universal definition for pharmacy deserts is leading to a significant impact on patients’ access and outcomes.

Pharmacy Times

JULY 21, 2025

Critically ill patients treated with a pharmacist-managed insulin protocol achieved higher rates of glucose control than those treated with conventional methods.

Drug Topics

JULY 21, 2025

Community pharmacists play a crucial role in helping patients start insulin with confidence through education, emotional support, and hands-on guidance.

Speaker: Chris Antypas and Josh Halladay

Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.

Pharmacy Times

JULY 21, 2025

News All News FDA Updates Press Releases Media All Videos Digital Detail Independent Corner Insights Interviews MEDcast Medical World News Microsites Peer Exchange Perfect Consult Podcasts Practice Pearls Sponsored Webcast Student Voices Webinars/Webcasts Conferences Conference Coverage Conference Listing Publications Pharmacy Times Pharmacy Practice in Focus: Oncology Pharmacy Practice in Focus: Health Systems Pharmacy Careers All Publications About the Publications Author Submission Submit to

Compounding Pharmacies

Drug Topics

JULY 21, 2025

News FDA Updates Law and Advocacy Technology Trends Viewpoints All News Media In-Depth Insights Pharmacist View Script-Ed Expert Interviews Podcasts Conferences Conference Coverage Conference Listing Resources Disease Awareness White Board Video American Pharmacists Month Sponsored Resources CME/CE Partners Publications Drug Topics Journal Total Pharmacy Journal Submission of Articles Events Virtual Events Total Pharmacy Solutions Summit Business Business Strategies Patient Services Pharmacy Inv

Specialty Pharmacies

Pharmacy Times

JULY 21, 2025

Pharmacists play a critical role in preventing medication ordering errors during residency onboarding through proactive training, system safeguards, and interdisciplinary collaboration.

PharmTech

JULY 21, 2025

George Francis Tidmarsh, MD, PhD, founding co-director of Stanford’s Master of Translational Research and Applied Medicine program, has been appointed as the new director of the Center for Drug Evaluation and Research.

FDA

Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist

What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.

FDA

European Pharmaceutical Review

JULY 21, 2025

The UK Medicines and Healthcare products Regulatory Agency (MHRA) has approved the first needle-free adrenaline nasal spray for emergency use during allergic reactions (anaphylaxis) in the UK. EURneffy (adrenaline nasal spray ) ® is a ready-to-use treatment indicated for adults and children weighing greater than 30kg. This news follows launch of the medicine in Germany last month.

Pharmacy Times

JULY 21, 2025

News All News FDA Updates Press Releases Media All Videos Digital Detail Independent Corner Insights Interviews MEDcast Medical World News Microsites Peer Exchange Perfect Consult Podcasts Practice Pearls Sponsored Webcast Student Voices Webinars/Webcasts Conferences Conference Coverage Conference Listing Publications Pharmacy Times Pharmacy Practice in Focus: Oncology Pharmacy Practice in Focus: Health Systems Pharmacy Careers All Publications About the Publications Author Submission Submit to

HIV Treatment and Prevention Agents

Pharmaceutical Commerce

JULY 21, 2025

In the final part of his Pharma Commerce video interview, Sean O’Hearen, founder and principal consultant at 1st Line Partners, offers communication strategies for staying confident in genuine pharmaceuticals while also remaining vigilant against counterfeit threats.

Communication

Drug Topics

JULY 21, 2025

More pharmacists are moving into nontraditional roles within health care, driven by limited advancement opportunities, stagnant wages, and a growing desire for flexibility

Advertisement

Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.

Pharmacy Management Software

PharmaVoice

JULY 21, 2025

West’s new flexible line for pens and autoinjectors, launching Q1 2026, will streamline assembly, labeling, packaging and testing for clinical volumes and drive cost efficiency.

Packaging

Pharmacy Times

JULY 21, 2025

Panelists discuss how the patient journey with tardive dyskinesia involves evolving awareness and management of symptoms alongside underlying psychiatric conditions, highlighting the distinct needs of younger vs older patients and the essential role of pharmacists in supporting individualized, function-focused care throughout the lifespan.

OctariusRx

JULY 21, 2025

Preview the new medications of 2025, as we reach the halfway point of the year. The U.S. Food and Drug Administration (FDA) is constantly reviewing and approving new medications and the number of medications approved in recent years has drastically increased. Keeping up with all the changes can be a full-time job. In this post, we look at the most recent approvals to keep you informed and ensure patient safety.

FDA

Pharmaceutical Commerce

JULY 21, 2025

Industry stakeholders suggest how pharmaceutical companies can proactively plan for the potential implementation of a Most Favored Nation (MFN) pricing model.

Pharmaceutical Companies

Pharmacy Times

JULY 21, 2025

A pharmacist's termination raises critical questions about staffing policies, patient safety, and ethical obligations in healthcare. Explore the ongoing legal battle.

Pharmaceutical Commerce

JULY 21, 2025

The acquisition merges eBlu’s automation platform with Knipper’s nationwide distribution network, streamlining benefit verification, prior authorization, and patient onboarding while reducing administrative burdens for specialty providers.

PharmaVoice

JULY 21, 2025

Skip to main content Dont miss the most important voices in pharma Let PharmaVoices free newsletter keep you informed on what industry leaders are saying, straight from your inbox. By signing up to receive our newsletter, you agree to our Terms of Use and Privacy Policy. You can unsubscribe at anytime. Voices Q&A Profiles Biotech Spotlight First 90 Days Opinions Topics Biotech Commercialization Leadership Manufacturing Patient Pharma Policy & Regulation Research & Development Library Eve

FDA

Pharmacy Times

JULY 21, 2025

Panelists discuss how extended-release VMAT2 inhibitor formulations improve adherence and tolerability through once-daily dosing and easier administration options, while emphasizing the importance of tailoring treatment to patient needs and the promise of emerging therapies in the pipeline.

Pharmafile

JULY 21, 2025

Boehringer Ingelheim and LEO Pharma have partnered to commercialise and further develop Spevigo (spesolimab), a treatment for generalised pustular psoriasis (GPP), a rare and potentially life-threatening skin disease. Under the agreement, LEO Pharma will assume global responsibility for commercialising and advancing the development of Spevigo, building on Boehringer’s launch of the drug in over 40 […] The post Boehringer Ingelheim and LEO Pharma partner to develop treatment for generalised

Pharmaceutical Technology

JULY 21, 2025

Skip to site menu Skip to page content Switch language: translate --> PT Menu Search Sections Home News Analysis Features Comment & Opinion Projects Data Insights Sectors Clinical Trials Drug Manufacturers Therapy Area Cardiovascular Central Nervous System Immunology Infectious Disease Oncology Respiratory Pricing and Market Access Themes Artificial Intelligence Corporate Governance Cloud Cybersecurity Environmental Sustainability Internet of Things Robotics Social Responsibility Covid-19 Insigh

Packaging

pharmaphorum

JULY 21, 2025

The FDA has rounded out its senior leadership by naming biopharma industry executive George Tidmarsh to the role of CDER director

FDA

Hospital Pharmacy Europe

JULY 21, 2025

The General Pharmaceutical Council (GPhC) will push forward with a 6% increase in its annual registration fees this year despite strong opposition from the profession. However, plans for an additional rise in 2026 have been put on hold to allow for further reflection on concerns raised by registrants. The regulator was given the greenlight from its governing council to increase pharmacist renewal fees by £17 to £293 from September 2025.

Insurance

Pharmaceutical Technology

JULY 21, 2025

Skip to site menu Skip to page content Switch language: translate --> PT Menu Search Sections Home News Analysis Features Comment & Opinion Projects Data Insights Sectors Clinical Trials Drug Manufacturers Therapy Area Cardiovascular Central Nervous System Immunology Infectious Disease Oncology Respiratory Pricing and Market Access Themes Artificial Intelligence Corporate Governance Cloud Cybersecurity Environmental Sustainability Internet of Things Robotics Social Responsibility Covid-19 Insigh

Packaging

Pharma Manufacturing

JULY 21, 2025

Magazine ENEWS SUBSCRIBE WEBINARS PODCASTS EBOOKS ABOUT US Edit submissions Media kit Innovation Awards Articles CDMO sector to remain largely unaffected by US tariffs, finds Morningstar DBRS July 21, 2025 While supply chain disruptions may arise, contract development and manufacturing organizations are resilient, contends the credit ratings agency.

Dosage

The Checkup by Singlecare

JULY 21, 2025

Aripiprazole is an FDA-approved medication used to treat mental health conditions, such as bipolar disorder, irritability associated with autism spectrum disorder, major depressive disorder (MDD), schizophrenia, and Tourette’s Syndrome. Also known by the brand name Abilify , this atypical antipsychotic medication balances dopamine and serotonin levels in the brain to help regulate mood, behavior, and thoughts.

Labelling